Spots Global Cancer Trial Database for stage iiia breast cancer
Every month we try and update this database with for stage iiia breast cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Trastuzumab for 6 Months or 1 Year in Treating Women With Nonmetastatic Breast Cancer That Can Be Removed By Surgery | NCT00381901 | Breast Cancer | trastuzumab polymorphism an... adjuvant therap... | 18 Years - | National Cancer Institute (NCI) | |
| Trastuzumab and Letrozole in Treating Postmenopausal Women With Progressive Advanced Breast Cancer | NCT00238290 | Breast Cancer | Trastuzumab + L... | 18 Years - 120 Years | Swiss Group for Clinical Cancer Research | |
| A Study to Evaluate Genetic Predictors of Aromatase Inhibitor Musculoskeletal Symptoms (AIMSS) | NCT01824836 | Estrogen Recept... Musculoskeletal... Progesterone Re... Recurrent Breas... Stage IA Breast... Stage IB Breast... Stage II Breast... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... | anastrozole questionnaire a... laboratory biom... pharmacogenomic... | 18 Years - | Eastern Cooperative Oncology Group | |
| S0230 Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer | NCT00068601 | Breast Cancer Infertility Menopausal Symp... | cyclophosphamid... goserelin aceta... | 18 Years - 49 Years | SWOG Cancer Research Network | |
| Prolonged Tamoxifen Compared With Shorter Tamoxifen in Treating Patients Who Have Breast Cancer | NCT00003016 | Breast Cancer | tamoxifen citra... adjuvant therap... | - | National Cancer Institute (NCI) | |
| Combination Chemotherapy, Amifostine, and Peripheral Stem Cell Transplantation in Treating Patients With Stage II, Stage III, or Stage IV Breast Cancer | NCT00003927 | Breast Cancer | filgrastim amifostine trih... cyclophosphamid... doxorubicin hyd... paclitaxel peripheral bloo... | 18 Years - 59 Years | City of Hope Medical Center | |
| IH636 Grape Seed Extract in Treating Hardening of Breast Tissue in Women Who Have Undergone Radiation Therapy for Early Breast Cancer | NCT00041223 | Breast Cancer Radiation Fibro... | IH636 grape see... | 18 Years - | National Cancer Institute (NCI) | |
| Chemotherapy in Treating Patients With Breast Cancer | NCT00012129 | Breast Cancer | liposomal annam... | 18 Years - 120 Years | NYU Langone Health | |
| Radiation Therapy After Surgery in Treating Women With Early Stage Breast Cancer | NCT00005587 | Breast Cancer | radiation thera... | 18 Years - | National Cancer Institute (NCI) | |
| Alkaline Water in Reducing Skin Toxicity in Women With Breast Cancer Undergoing Radiation Therapy | NCT01487954 | Radiation Toxic... Recurrent Breas... Stage I Breast ... Stage II Breast... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... Stage IV Breast... | alkaline water distilled water external beam r... | 18 Years - | Case Comprehensive Cancer Center | |
| Adjuvant Stage 2-3A Breast Cancer With Positive Lymph Nodes | NCT00007904 | Breast Cancer | filgrastim cyclophosphamid... doxorubicin hyd... paclitaxel tamoxifen citra... adjuvant therap... radiation thera... | 18 Years - | Case Comprehensive Cancer Center | |
| Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Positive Breast Cancer | NCT00093795 | Breast Cancer | Cyclophosphamid... Docetaxel Gemcitabine Paclitaxel Doxorubicin | 18 Years - | NSABP Foundation Inc | |
| Trastuzumab in Treating Women With HER2-Positive Early Breast Cancer | NCT00712140 | Breast Cancer | trastuzumab parenteral chem... | 18 Years - | National Cancer Institute (NCI) | |
| Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer | NCT00005842 | Cancer | trastuzumab tipifarnib | 18 Years - | National Cancer Institute (NCI) | |
| Docetaxel in Treating Patients With Solid Tumors and Abnormal Liver Function | NCT00002901 | Breast Cancer Head and Neck C... Lung Cancer Ovarian Cancer Unspecified Adu... | docetaxel | 18 Years - | City of Hope Medical Center | |
| Bevacizumab and Letrozole in Treating Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer That Cannot Be Removed By Surgery | NCT00305825 | Breast Cancer | bevacizumab letrozole | 18 Years - 120 Years | University of California, San Francisco | |
| Breast Cancer Rehabilitation Program in Improving Quality of Life in Breast Cancer Survivors | NCT01113554 | Stage I Breast ... Stage II Breast... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... Stage IV Breast... | questionnaire a... exercise interv... quality-of-life... survey administ... management of t... psychosocial as... | 18 Years - | Wake Forest University Health Sciences | |
| Yoga in Controlling Symptoms and Reducing Stress in Women With Ovarian Cancer or Breast Cancer | NCT00337233 | Breast Cancer Fatigue Ovarian Cancer Psychosocial Ef... | yoga therapy | 18 Years - 120 Years | Wake Forest University Health Sciences | |
| Testosterone in Treating Postmenopausal Patients With Arthralgia Caused by Adjuvant Aromatase Inhibitor Treatment | NCT01573442 | Arthralgia Breast Cancer Hot Flashes Musculoskeletal... Sexual Dysfunct... | testosterone placebo | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Paclitaxel With or Without Gemcitabine in Treating Women With Advanced Breast Cancer | NCT00006459 | Breast Cancer | gemcitabine hyd... paclitaxel | 18 Years - | Eli Lilly and Company | |
| High-Dose Chemotherapy and Autologous Blood Cell Transplantation in Treating Patients With Primary, Locally Advanced, or Stage IV Breast Cancer | NCT00003068 | Breast Cancer Drug/Agent Toxi... | amifostine trih... cyclophosphamid... mitoxantrone hy... thiotepa peripheral bloo... | 16 Years - 70 Years | National Cancer Institute (NCI) | |
| Aerobic and Strength Training Exercise in Improving Fitness and Arm Health During and After Radiation Therapy in Patients With Stage II-III Breast Cancer | NCT03102866 | Stage II Breast... Stage IIA Breas... Stage IIB Breas... Stage III Breas... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... | Best Practice Exercise Interv... Quality-of-Life... Questionnaire A... | - | Ohio State University Comprehensive Cancer Center | |
| Compliance to a Hormone Therapy Regimen in Breast Cancer | NCT00666822 | Breast Cancer | compliance moni... medical chart r... questionnaire a... | 18 Years - | Case Comprehensive Cancer Center | |
| Cu64-DOTA-trastuzumab PET and Markers Predicting Response to Neoadjuvant Trastuzumab + Pertuzum in HER2+ Breast Cancer | NCT02827877 | HER2 Positive B... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... | Copper Cu 64-DO... Laboratory Biom... Pertuzumab Positron Emissi... Therapeutic Con... Trastuzumab | 18 Years - | City of Hope Medical Center | |
| Hormone Therapy in Treating Postmenopausal Women With Receptor-Positive Breast Cancer | NCT00002646 | Breast Cancer | fenretinide tamoxifen citra... | - | National Cancer Institute (NCI) | |
| Breast Density, Hormone Levels, and Anticancer Drug Levels in Women With Invasive Breast Cancer Who Are Receiving Exemestane or Anastrozole | NCT00316836 | Breast Cancer | mammography | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Docetaxel, Carboplatin, and Pegfilgrastim in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer | NCT00107510 | Breast Cancer | pegfilgrastim carboplatin docetaxel conventional su... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Evaluation of Patients With Breast Cancer Using DCE-MRI, MRS, and Proteomics | NCT00656604 | Breast Cancer | proteomic profi... lumpectomy or m... dynamic contras... histopathologic... magnetic resona... | 18 Years - | Vanderbilt-Ingram Cancer Center | |
| Studying Biological Markers of Fatigue in Women With Residual Invasive Breast Cancer Enrolled on Clinical Trial NSABP-B-45 | NCT00914043 | Breast Cancer Fatigue | gene expression... microarray anal... polymerase chai... polymorphism an... reverse transcr... biologic sample... enzyme-linked i... laboratory biom... fatigue assessm... | - | NSABP Foundation Inc | |
| Trastuzumab for 6 Months or 1 Year in Treating Women With Nonmetastatic Breast Cancer That Can Be Removed By Surgery | NCT00381901 | Breast Cancer | trastuzumab polymorphism an... adjuvant therap... | 18 Years - | National Cancer Institute (NCI) | |
| Acupuncture in Treating Nerve Pain in Patients With Stage I, Stage II, or Stage III Breast Cancer Who Are Receiving Paclitaxel | NCT01050075 | Breast Cancer Stage I Breast ... Stage II Breast... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... | acupuncture the... questionnaire a... management of t... | 18 Years - | City of Hope Medical Center | |
| Development of a Questionnaire to Evaluate Patient Expectations for Breast Reconstruction in Women With Breast Cancer or Other Conditions | NCT00471601 | Breast Cancer | counseling inte... questionnaire a... psychosocial as... quality-of-life... | 18 Years - 75 Years | Memorial Sloan Kettering Cancer Center | |
| Palbociclib With Cisplatin or Carboplatin in Advanced Solid Tumors | NCT02897375 | Solid Neoplasm Stage III Pancr... Stage IIIA Brea... Stage IIIA Non-... Stage IIIB Brea... Stage IIIB Non-... Stage IIIC Brea... Stage IV Breast... Stage IV Non-Sm... Stage IVA Pancr... Stage IVB Pancr... Sarcoma Colorectal Canc... Head and Neck C... Cancer of Unkno... Bladder Cancer Ovarian Cancer | Carboplatin Cisplatin Palbociclib | 18 Years - | Emory University | |
| Combination Chemotherapy in Treating Women With Stage II or Stage IIIA Breast Cancer That Has Spread to the Lymph Nodes | NCT00004125 | Breast Cancer | cyclophosphamid... docetaxel doxorubicin hyd... paclitaxel tamoxifen citra... radiation thera... | 18 Years - 120 Years | Eastern Cooperative Oncology Group | |
| Phase I/II Study of Neoadjuvant Lapatinib in Breast Cancer | NCT00450892 | Breast Cancer | docetaxel+lapat... docetaxel + tra... docetaxel + tra... | 18 Years - 70 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
| S0307 Phase III Trial of Bisphosphonates as Adjuvant Therapy for Primary Breast Cancer. | NCT00127205 | Breast Cancer | clodronate diso... ibandronate sod... zoledronic acid | 18 Years - | SWOG Cancer Research Network | |
| Cardiac Rehabilitation Program in Improving Cardiorespiratory Fitness in Stage 0-III Breast Cancer Survivors | NCT03039140 | Cancer Survivor Stage 0 Breast ... Stage IA Breast... Stage IB Breast... Stage IIA Breas... Stage IIB Breas... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... | Educational Int... Exercise Interv... Quality-of-Life... Questionnaire A... | 30 Years - 75 Years | Ohio State University Comprehensive Cancer Center | |
| Abraxane and Lapatinib in Treating Patients With Stage I, Stage II, or Stage III Breast Cancer | NCT00331630 | Breast Cancer | lapatinib ditos... paclitaxel albu... | 18 Years - | Northwestern University | |
| Development of a Questionnaire to Evaluate Patient Expectations for Breast Reconstruction in Women With Breast Cancer or Other Conditions | NCT00471601 | Breast Cancer | counseling inte... questionnaire a... psychosocial as... quality-of-life... | 18 Years - 75 Years | Memorial Sloan Kettering Cancer Center | |
| Combination Chemotherapy With or Without Colony-stimulating Factors in Treating Women With Breast Cancer | NCT00014222 | Breast Cancer | epoetin alfa filgrastim cyclophosphamid... doxorubicin hyd... epirubicin hydr... fluorouracil paclitaxel | - 60 Years | Canadian Cancer Trials Group | |
| Compliance to a Hormone Therapy Regimen in Breast Cancer | NCT00666822 | Breast Cancer | compliance moni... medical chart r... questionnaire a... | 18 Years - | Case Comprehensive Cancer Center | |
| Cranial Stimulation for Chemotherapy Symptoms in Breast Cancer | NCT00902330 | Anxiety Disorde... Breast Cancer Depression Fatigue Pain Sleep Disorders | energy-based th... sham interventi... | 18 Years - | Virginia Commonwealth University | |
| Survival TRaining for ENhancing Total Health (STRENGTH) | NCT00068458 | Breast Cancer Depression Weight Changes | Calcium-Rich Di... Arm 2: Exercise... Exercise + Frui... | 18 Years - | Duke University | |
| Assessing the Accuracy of Tumor Biopsies After Chemotherapy to Determine if Patients Can Avoid Breast Surgery | NCT03188393 | Invasive Breast... Stage II Breast... Stage IIA Breas... Stage IIB Breas... Stage IIIA Brea... | Biopsy of Breas... | 18 Years - | NRG Oncology | |
| Interactive Gentle Yoga in Improving Quality of Life in Patients With Stage I-III Breast Cancer Undergoing Radiation Therapy | NCT02023008 | Anxiety Disorde... Depression Ductal Breast C... Fatigue Stage IA Breast... Stage IB Breast... Stage II Breast... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... | yoga therapy internet-based ... questionnaire a... | 18 Years - | Wake Forest University Health Sciences | |
| Veliparib, Oxaliplatin, and Capecitabine in Treating Patients With Advanced Solid Tumors | NCT01233505 | Adenocarcinoma ... Adenocarcinoma ... BRCA1 Mutation ... BRCA2 Mutation ... Ovarian Mucinou... Recurrent Breas... Recurrent Colon... Recurrent Gastr... Recurrent Ovari... Recurrent Ovari... Recurrent Pancr... Recurrent Recta... Stage IA Breast... Stage IB Breast... Stage II Breast... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... Stage IV Breast... Stage IV Colon ... Stage IV Gastri... Stage IV Ovaria... Stage IV Ovaria... Stage IV Pancre... Stage IV Rectal... Unspecified Adu... | veliparib capecitabine oxaliplatin pharmacological... laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer | NCT00516698 | Breast Cancer | polymorphism an... high performanc... laboratory biom... radiomammograph... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Identifying Genes That Predict Recurrence in Women With Breast Cancer Treated With Chemotherapy | NCT00897299 | Breast Cancer Estrogen Recept... Her-2 Pgr | microarray anal... protein express... immunohistochem... laboratory biom... | 18 Years - 120 Years | Eastern Cooperative Oncology Group | |
| Studying Changes in Breast Density in Patients With Early-Stage Breast Cancer Treated With Metformin Hydrochloride or Placebo on CAN-NCIC-MA.32 | NCT01666171 | Breast Cancer | metformin hydro... clinical observ... diagnostic labo... imaging biomark... medical chart r... digital mammogr... | 18 Years - 74 Years | National Cancer Institute (NCI) | |
| PET Scans in Assessing Response To Treatment in Patients Receiving Hormone Therapy or Trastuzumab for Breast Cancer | NCT00362973 | Breast Cancer | laboratory biom... needle biopsy positron emissi... radionuclide im... fludeoxyglucose... | 18 Years - 120 Years | University of Washington | |
| Combination Chemotherapy in Treating Patients With Early Stage Breast Cancer That Has Been Removed By Surgery | NCT00301925 | Breast Cancer | pegfilgrastim capecitabine cyclophosphamid... epirubicin hydr... fluorouracil methotrexate adjuvant therap... | 18 Years - 120 Years | Institute of Cancer Research, United Kingdom | |
| St. John's Wort in Relieving Hot Flashes in Postmenopausal Women With Non-Metastatic Breast Cancer | NCT00110136 | Breast Cancer Hot Flashes | St. John's Wort | 18 Years - | Wake Forest University Health Sciences | |
| Assessing the Accuracy of Tumor Biopsies After Chemotherapy to Determine if Patients Can Avoid Breast Surgery | NCT03188393 | Invasive Breast... Stage II Breast... Stage IIA Breas... Stage IIB Breas... Stage IIIA Brea... | Biopsy of Breas... | 18 Years - | NRG Oncology | |
| Sentinel Lymph Node Biopsy and Primary Tumor Gene Expression Profiling in Finding Axillary Lymph Node Metastases in Women Who Have Received Neoadjuvant Therapy for Stage II, Stage III, or Stage IV Breast Cancer | NCT00080860 | Breast Cancer | microarray anal... immunohistochem... conventional su... lymphangiograph... radionuclide im... sentinel lymph ... technetium Tc 9... | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Combination Chemotherapy in Treating Women With Breast Cancer | NCT00003679 | Breast Cancer | cyclophosphamid... docetaxel doxorubicin hyd... tamoxifen citra... conventional su... radiation thera... | 18 Years - 60 Years | National Cancer Institute (NCI) | |
| Combination Chemotherapy in Treating Women With Stage I, Stage II, or Stage IIIA (cT1-3, N0-1, M0) Breast Cancer and Positive Axillary Lymph Nodes | NCT00003782 | Breast Cancer | cyclophosphamid... docetaxel doxorubicin | 18 Years - 120 Years | NSABP Foundation Inc | |
| Docetaxel or Paclitaxel in Treating Women With Unresectable Locally Advanced or Metastatic Breast Cancer | NCT00006120 | Breast Cancer | docetaxel paclitaxel | 18 Years - 75 Years | National Cancer Institute (NCI) | |
| Strength and Range of Motion in Women Undergoing Surgery for Breast Cancer | NCT00489125 | Breast Cancer | physiologic tes... | - 120 Years | Wake Forest University Health Sciences | |
| Omega-3 Fatty Acid in Treating Patients With Stage I-III Breast Cancer | NCT01869764 | Ductal Breast C... Lobular Breast ... Male Breast Can... Stage IA Breast... Stage IB Breast... Stage II Breast... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... | omega-3 fatty a... placebo laboratory biom... | 18 Years - | Wake Forest University Health Sciences | |
| Perifosine in Treating Patients With Recurrent, Refractory, Locally Advanced, or Metastatic Breast Cancer | NCT00054145 | Breast Cancer | perifosine | 18 Years - | University Health Network, Toronto | |
| Genetic Counseling or Usual Care in Helping Women With Newly Diagnosed Ductal Carcinoma In Situ or Stage I, Stage II, or Stage IIIA Breast Cancer Make Treatment Decisions | NCT00262899 | Breast Cancer Psychosocial Ef... | counseling inte... educational int... psychosocial as... | 18 Years - | Georgetown University | |
| Arsenic Trioxide in Treating Women With Locally Advanced or Metastatic Breast Cancer | NCT00075413 | Breast Cancer | arsenic trioxid... | 18 Years - 120 Years | The University of Texas Medical Branch, Galveston | |
| Genetic Testing in Predicting Response to Paclitaxel in Women With Breast Cancer | NCT00088829 | Breast Cancer | paclitaxel microarray anal... biopsy neoadjuvant the... Paclitaxel | 18 Years - | Georgetown University | |
| Combination Chemotherapy With or Without Darbepoetin Alfa in Treating Women With Stage III Breast Cancer | NCT00309920 | Breast Cancer | darbepoetin alf... cyclophosphamid... docetaxel doxorubicin hyd... epirubicin hydr... fluorouracil | 18 Years - 65 Years | National Cancer Institute (NCI) | |
| Trastuzumab in Treating Women With HER2-Positive Early Breast Cancer | NCT00712140 | Breast Cancer | trastuzumab parenteral chem... | 18 Years - | National Cancer Institute (NCI) | |
| Anastrozole With or Without Gefitinib in Treating Postmenopausal Women With Metastatic or Locally Recurrent Breast Cancer | NCT00066378 | Breast Cancer | anastrozole gefitinib | - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Diet and Exercise or Normal Care in Overweight or Obese Women Who Have Undergone Treatment for Stage I, Stage II, or Stage III Breast Cancer | NCT00689975 | Breast Cancer | behavioral diet... exercise interv... counseling inte... flow cytometry immunoenzyme te... laboratory biom... complementary o... standard follow... | - | National Cancer Institute (NCI) | |
| Prolonged Tamoxifen Compared With Shorter Tamoxifen in Treating Patients Who Have Breast Cancer | NCT00003016 | Breast Cancer | tamoxifen citra... adjuvant therap... | - | National Cancer Institute (NCI) | |
| Combination Chemotherapy Plus Biological Therapy in Treating Patients With Stage II or Stage III Breast Cancer | NCT00022230 | Breast Cancer | aldesleukin filgrastim sargramostim therapeutic aut... cyclophosphamid... doxorubicin hyd... paclitaxel | 18 Years - | Roger Williams Medical Center | |
| Lapatinib and Radiation Therapy in Treating Patients With Locally Recurrent or Chemotherapy-Refractory Locally Advanced or Metastatic Breast Cancer | NCT00379509 | Breast Cancer | lapatinib ditos... TdT-mediated dU... gene expression... microarray anal... immunohistochem... biopsy radiation thera... | 18 Years - 120 Years | UNC Lineberger Comprehensive Cancer Center | |
| Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer | NCT00516698 | Breast Cancer | polymorphism an... high performanc... laboratory biom... radiomammograph... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Cranial Stimulation for Chemotherapy Symptoms in Breast Cancer | NCT00902330 | Anxiety Disorde... Breast Cancer Depression Fatigue Pain Sleep Disorders | energy-based th... sham interventi... | 18 Years - | Virginia Commonwealth University | |
| Acupuncture in Reducing Muscle and Bone Symptoms in Women Receiving Letrozole, Exemestane, or Anastrozole for Stage 0, Stage I, Stage II, or Stage III Breast Cancer | NCT00641303 | Anxiety Disorde... Breast Cancer Depression Fatigue Hot Flashes Pain Sleep Disorders | acupuncture the... sham interventi... | 18 Years - | University of Maryland, Baltimore | |
| Black Cohosh in Treating Hot Flashes in Women Who Have or Who Are At Risk of Developing Breast Cancer | NCT00060320 | Breast Cancer Hot Flashes | black cohosh placebo | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Azacitidine in Treating Patients With Triple Negative Stage I-IV Invasive Breast Cancer That Can Be Removed By Surgery | NCT01292083 | Recurrent Breas... Stage IA Breast... Stage IB Breast... Stage II Breast... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... Stage IV Breast... Triple-negative... | azacitidine laboratory biom... immunohistochem... polymerase chai... western blottin... nucleic acid se... therapeutic con... | 18 Years - | University of Southern California | |
| Sunitinib Malate and Exemestane in Treating Postmenopausal Women With Breast Cancer | NCT00931450 | Breast Cancer | exemestane sunitinib malat... placebo | - | National Cancer Institute (NCI) | |
| Docetaxel, Doxorubicin, and Cyclophosphamide in Treating Women With Stage III Breast Cancer | NCT00004175 | Breast Cancer | cyclophosphamid... docetaxel doxorubicin hyd... conventional su... | 18 Years - | Northwestern University | |
| Ganetespib, Paclitaxel, Trastuzumab and Pertuzumab for Metastatic Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer | NCT02060253 | HER2-positive B... Male Breast Can... Recurrent Breas... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... Stage IV Breast... | ganetespib paclitaxel trastuzumab pertuzumab | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Trastuzumab or Observation After Combination Chemotherapy and Trastuzumab in Treating Patients Undergoing Surgery for Stage II or Stage III Breast Cancer | NCT00533936 | Breast Cancer | trastuzumab cyclophosphamid... doxorubicin hyd... fluorouracil paclitaxel adjuvant therap... conventional su... neoadjuvant the... | 18 Years - 65 Years | National Cancer Institute (NCI) | |
| Hatha Yoga in Improving Physical Activity, Inflammation, Fatigue, and Distress in Breast Cancer Survivors | NCT00486525 | Breast Cancer Depression Fatigue Pain | Yoga Therapy | 21 Years - | Ohio State University Comprehensive Cancer Center |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
